Drug Discovery
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Methods Development | R&D
CRISPR & ProBioGen Announce Research Collaboration
Focused on the development of novel in vivo delivery modalities for CRISPR/Cas9 leveraging ProBioGen’s existing technology and expertise01.22.19
-
Bio News | Drug Development | Drug Discovery | Industry News | Trials & Filings
FDA Approves MabPlex's IND
MabPlex was contracted to develop and manufacture the product from cell line development to IND filing in both the United States and China01.16.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Biomunex & Sanofi Enter Licensing Agreement
Sanofi will have access to Biomunex' proprietary technology to generate and optimize bi- and multi-specific antibody therapeutics01.15.19
-
Bio News | Drug Discovery | Facilities | Industry News | Promotions & Moves
Averica Announces New Leadership Team
Along with the promotions, the company announced the move to a larger 16,000 sq ft facility adjacent to the vibrant Boston life sciences hub01.14.19
-
cGMP Manufacture | Clinical Trial Materials | Drug Development | Drug Discovery | Regulatory Affairs
CDMO Outsourcing Trends
iBio’s R. Barry Holtz discusses the trends driving R&D and outsourcing, as well as some of the biggest opportunities for CDMOsOnline Exclusives Kristin Brooks, Contract Pharma 01.11.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Johnson Matthey, Immunomedics Partner for Cancer
Strategic manufacturing partnership is for the large-scale production of the drug-linker used in Immunomedics’ lead antibody-drug conjugate01.10.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
CANbridge, WuXi Biologics Expand Partnership
Their rare disease partnership will enable CANbridge to discover, develop and commercialize four additional drug candidates01.08.19
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Fujifilm Expands Cancer Drug Delivery Research
Will focus on nucleic acid-liposome drug delivery system01.04.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Sarepta, Aldevron Enter Gene Therapy Agreement
Strategic relationship is for the supply of plasmid DNA to fulfill Sarepta’s needs for its gene therapy clinical trials and commercial supply01.02.19
-
Bio News | Drug Development | Drug Discovery | Industry News | R&D | Trials & Filings
FDA Grants ProQR FTD
For QR-421a, a first-in-class investigational RNA-based oligonucleotide01.02.19
-
Breaking News | Drug Development | Drug Discovery | Industry News
Staten Biotechnology and Novo Nordisk in Cardiovascular Tie-up
Collaboration to develop novel treatment for dyslipidaemia; could be worth up to €430 million12.28.18
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Chi-Med and Lilly Amend 2013 Agreement
Change in responsibilities for the development & commercialization, collaborations, and distribution of fruquintinib in multiple areas12.20.18
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Roquette & Thermo Fisher Enter Distribution Deal
For the Roquette portfolio of pharmaceutical ingredients in the United States and Canada12.18.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Proteostasis & Genentech Sign Licensing Deal
For rights to potential therapeutic small molecule modulators of an undisclosed target within the proteostasis network12.17.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | Laboratory Testing | R&D
Alkermes, Biogen Submit NDA to FDA
For diroximel fumarate (BIIB098), a novel oral fumarate in development for the treatment of relapsing forms of multiple sclerosis12.17.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
KIO, Pfizer Enter Research Collaboration
To develop RIG-I agonist immunotherapies for the treatment of cancer12.17.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Q BioMed, SRI Enter ASD Collaboration
To provide formulation development, preclinical development, and early clinical manufacturing of QBM-001 for non-verbal or minimally verbal autistic children12.13.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
AC Immune & Lilly Partner for Alzheimer's
The license and collaboration agreement is to research and develop tau aggregation inhibitor small molecules for the potential treatment of AD12.12.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Facilities | Industry News | Solid Dosage/Semi-solids
Federal Equipment & Investor Group Purchase Pharma Campus
The 110 acre, 800,000 sq. ft. site's features & capabilities include solid dosage form, liquid manufacturing filling, distribution warehouse, and vault storage12.11.18
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
InveniAI, Kyowa Hakko Kirin Partner for Drug Discovery
Together using artificial intelligence and machine learning, will leverage InveniAI's AlphaMeld platform for further discovery12.11.18
